- Filed
- Sep 2, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Oct 24, 2024 | 102.27M sh |
| Shares Diluted | Q1 2025 · Aug 31, 2024 | 101.71M sh |
| Shares Diluted | Q1 2025 · Aug 31, 2023 | 101.71M sh |
| Operating Cash Flow | Q1 2025 · Aug 31, 2024 | $75.88K |
| Operating Cash Flow | Q1 2025 · Aug 31, 2023 | $100.46K |
| Cash And Equivalents | Q1 2025 · Aug 31, 2024 | $72.05K |
| Cash And Equivalents | Q1 2025 · May 31, 2024 | $2.52K |
| Stockholders Equity | Q1 2025 · Aug 31, 2024 | $307.53K |
| Stockholders Equity | Q1 2025 · May 31, 2024 | $364.54K |
| Current Liabilities | Q1 2025 · Aug 31, 2024 | $2.14M |
| Current Liabilities | Q1 2025 · May 31, 2024 | $1.98M |
| Total Liabilities | Q1 2025 · Aug 31, 2024 | $2.14M |
| Total Liabilities | Q1 2025 · May 31, 2024 | $1.99M |
| Current Assets | Q1 2025 · Aug 31, 2024 | $631.23K |
| Current Assets | Q1 2025 · May 31, 2024 | $535.3K |
| Total Assets | Q1 2025 · Aug 31, 2024 | $2.45M |
| Total Assets | Q1 2025 · May 31, 2024 | $2.36M |
| Eps Diluted | Q1 2025 · Aug 31, 2024 | $0.00 |
| Eps Diluted restated | Q1 2025 · Aug 31, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Aug 31, 2024 | $0.00 |
| Eps Basic restated | Q1 2025 · Aug 31, 2023 | $0.00 |
| Sga Expense | Q1 2025 · Aug 31, 2024 | $82.55K |
| Sga Expense | Q1 2025 · Aug 31, 2023 | $634.93K |
| Net Income | Q1 2025 · Aug 31, 2024 | −$41.57K |
| Net Income | Q1 2025 · Aug 31, 2023 | −$502.94K |
| Operating Income restated | Q1 2025 · Aug 31, 2024 | −$43.83K |
| Operating Income | Q1 2025 · Aug 31, 2023 | −$506.32K |
| Gross Profit | Q1 2025 · Aug 31, 2024 | $95.01K |
| Gross Profit | Q1 2025 · Aug 31, 2023 | $280.59K |
| Cost Of Revenue | Q1 2025 · Aug 31, 2024 | $19.37K |
| Cost Of Revenue | Q1 2025 · Aug 31, 2023 | $223.93K |
| Capex | Q1 2025 · Aug 31, 2023 | $2.3K |